Mark Ragosa - 01 Sep 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Sep 2024
Net transactions value
-$85,996
Form type
4
Filing time
04 Sep 2024, 20:51:55 UTC
Previous filing
25 Jul 2024
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +4,444 +22% 24,313 01 Sep 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $60,432 -2,260 -9.3% $26.74 22,053 01 Sep 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise +1,861 +8.4% 23,914 02 Sep 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $25,563 -956 -4% $26.74 22,958 02 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +6,365 $0.000000 6,365 01 Sep 2024 Class A Ordinary Share 6,365 Direct F1, F2
transaction KNSA Share Option Award $0 +33,150 $0.000000 33,150 01 Sep 2024 Class A Ordinary Share 33,150 $26.74 Direct F3
transaction KNSA Restricted Share Unit Options Exercise $0 -2,694 -33% $0.000000 5,388 01 Sep 2024 Class A Ordinary Share 2,694 Direct F1, F4
transaction KNSA Restricted Share Unit Options Exercise $0 -1,750 -25% $0.000000 5,250 01 Sep 2024 Class A Ordinary Share 1,750 Direct F1, F5
transaction KNSA Restricted Share Unit Options Exercise $0 -1,861 -50% $0.000000 1,861 02 Sep 2024 Class A Ordinary Share 1,861 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
F3 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F6 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.